Cinna-Produkty Zdrowia Sp.z o.o.
FDA import alert and refusal historyPobiedziska, PolandFEI 3008196627
As of October 26, 2026, Cinna-Produkty Zdrowia Sp.z o.o. (Pobiedziska, Poland) is on the red list of FDA Import Alert 99-39 (Imported foods that appear to be misbranded) for lycolife lycopene drink; apple grape flavored; lycolife lycopene drink; apple peach flavored; lycolife lycopene drink; multi-fruit flavored; lycolife lycopene drink; apple pomegranate flavored; lycolife lycopene drink; apple mango flavored; lycolife lycopene drink; apple peach flavored, published by FDA on October 2, 2015, and has 1 FDA import refusal recorded since October 2016.
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- IA 99-39 · red list
- Last import refusal
- Soft drinks and waters not mentioned elsewhere, n.e.c. · NUTRIT LBL
- Last warning letter
- None found
- Last inspection
- None on record
Every FDA record for Cinna-Produkty Zdrowia Sp.z o.o.
2 records, newest first. Each line links to the FDA page it came from.
2019
- Import refusalRefused, Soft drinks and waters not mentioned elsewhere, n.e.c.NUTRIT LBLHEALTH CEntry AZ2-4008844-3Source
2015
- Import alert listingListed on Import Alert 99-39red listLycoLife Lycopene Drink; Apple Grape flavored; LycoLife Lycopene Drink; Apple Peach Flavored; LycoLife Lycopene Drink; Multi-Fruit Flavored; LycoLife Lycopene Drink; Apple Pomegranate flavored; LycoLife Lycopene Drink; Apple Mango Flavored; LycoLife Lycopene Drink; Apple Peach flavoredSource
Refusal charges, in plain English
- HEALTH C1 refused line
Unauthorized nutrient content or health claim
The label or labeling appeared to carry a nutrient content claim or health claim that is not authorized.
- NUTRIT LBL1 refused line
Nutrition information missing from label
The label or labeling appeared not to carry the nutrition information that U.S. law requires for the food.
Questions about Cinna-Produkty Zdrowia Sp.z o.o.
- Is Cinna-Produkty Zdrowia Sp.z o.o. on an FDA import alert?
- Yes. As of October 26, 2026, Cinna-Produkty Zdrowia Sp.z o.o. is on the red list of FDA Import Alert 99-39, “Imported foods that appear to be misbranded”, for lycolife lycopene drink; apple grape flavored; lycolife lycopene drink; apple peach flavored; lycolife lycopene drink; multi-fruit flavored; lycolife lycopene drink; apple pomegranate flavored; lycolife lycopene drink; apple mango flavored; lycolife lycopene drink; apple peach flavored; FDA published the listing on October 2, 2015.
- Has FDA refused shipments from Cinna-Produkty Zdrowia Sp.z o.o.?
- Yes. FDA refused 1 shipment line from Cinna-Produkty Zdrowia Sp.z o.o. on February 8, 2019. The most recent, on February 8, 2019, was soft drinks and waters not mentioned elsewhere, n.e.c., charged as NUTRIT LBL (nutrition information missing from label).
- Why did FDA refuse Cinna-Produkty Zdrowia Sp.z o.o.'s shipments?
- The most frequent charges are HEALTH C (unauthorized nutrient content or health claim, 1 line) and NUTRIT LBL (nutrition information missing from label, 1 line).
- What is Cinna-Produkty Zdrowia Sp.z o.o.'s FEI number?
- Cinna-Produkty Zdrowia Sp.z o.o.'s FDA Establishment Identifier (FEI) is 3008196627.
- Can shipments from Cinna-Produkty Zdrowia Sp.z o.o. still enter the U.S.?
- Shipments of lycolife lycopene drink; apple grape flavored; lycolife lycopene drink; apple peach flavored; lycolife lycopene drink; multi-fruit flavored; lycolife lycopene drink; apple pomegranate flavored; lycolife lycopene drink; apple mango flavored; lycolife lycopene drink; apple peach flavored from Cinna-Produkty Zdrowia Sp.z o.o. can be detained without physical examination under Import Alert 99-39; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).
Buying from Cinna-Produkty Zdrowia Sp.z o.o.?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.